Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2025
9-1-2025 MM-1089: Matching Efficacy and Safety in Clinical Trials vs Real-World Studies of Teclistamab in Relapsed/Refractory Multiple Myeloma, Sugam Gouli, Rochester Regional Health, Aliza Dulal, Bishal Tiwari, et al.
9-1-2025 POSTER: MM-1089 Matching Efficacy and Safety in Clinical Trials vs Real-World Studies of Teclistamab in Relapsed/Refractory Multiple Myeloma, Sugam Gouli, Rochester Regional Health, Aliza Dulal, Bishal Tiwari, et al.
9-1-2025 POSTER: TCL-1314 Central Nervous System T-Cell Lymphoma Secondary to Mycosis Fungoides: Diagnostic and Management Challenges—A Case Report, Mutasim Idriss, Rochester Regional Health, Zeinab Mohamed, Modather Grain, Rochester Regional Health, et al.
9-1-2025 TCL-1314: Central Nervous System T-Cell Lymphoma Secondary to Mycosis Fungoides: Diagnostic and Management Challenges—A Case Report, Mutasim Idriss, Rochester Regional Health, Zeinab Mohamed, Modather Grain, Rochester Regional Health, et al.
8-8-2025 BSLD-01 Prognostic Scoring and Histopathological Characteristics of Breast Cancer Patients with Leptomeningeal Metastases: Real-World Evidence from Multiple Tertiary Care Centers, Zauraiz Anjum, Rochester Regional Health, Sugam Gouli, Rochester Regional Health, Mahrukh Tariq, et al.
8-8-2025 RDTA-05 Bevacizumab for Radiation-Induced Brain Necrosis: A Systematic Review of Randomized Controlled Trials and Cohort Studies, Zauraiz Anjum, Rochester Regional Health, Mahrukh Tariq, Muhammad Umar Ejaz, et al.
8-8-2025 RDTA-14 Cognitive Decline from Whole Brain Radiation Therapy: A Systematic Review of Phase II and III Trials on Therapeutic Advances, Zauraiz Anjum, Rochester Regional Health, Mahrukh Tariq, Muhammad Umar Ejaz, et al.
7-19-2025 Engineering Innate Immunity: Recent Advances and Future Directions for CAR-NK and CAR-Macrophage Therapies in Solid Tumors, Behzad Amoozgar, Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA., Ayrton Bangolo, Department of Hematology and Oncology, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ 07601, USA., Charlene Mansour, Department of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA., et al.
6-10-2025 Unravelling VEXAS syndrome: shedding light on a recently recognised medical condition, Syeda Sarah Raza, Abdullah A. Orakzai, Rochester Regional Health, Ahmed Salman, Rochester Regional Health, et al.
6-1-2025 Diagnosis of Duffy Null-Associated Neutropenia During Chemotherapy, Zeni Kharel, Rochester Regional Health, Nicole Jean Rubin, Rochester Regional Health, Rachel David, Rochester Regional Health, et al.
6-1-2025 Efficacy of nanoliposomal irinotecan in metastatic pancreatic ductal adenocarcinoma: A meta-analysis of NAPOLI randomized clinical trials, Zauraiz Anjum, Rochester Regional Health, Gaurang Hasmukhbhai Suhagiya, Noorahman Noori, et al.
6-1-2025 Efficacy of nivolumab in advanced esophageal carcinoma: A systematic review of phase III clinical trials, Sundas Ali, Zauraiz Anjum, Rochester Regional Health, Gaurang Hasmukhbhai Suhagiya, et al.
6-1-2025 Exploring hidden risk: The prevalence of humoral immunodeficiency in patients with lymphoproliferative disorders—A prospective study, Hassan Saeed, Rochester Regional Health, Syed Usman Mohsin Ehsanullah, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, et al.
6-1-2025 Outcomes and prognostic factors in breast cancer patients with leptomeningeal metastasis: Insights from a retrospective analysis, Zauraiz Anjum, Rochester Regional Health, Sugam Gouli, Rochester Regional Health, Mahrukh Tariq, et al.
6-1-2025 Spot Urine Protein/Creatinine Ratio as an Alternative to 24-Hour Urine Collection for Measuring Proteinuria in Patients With Multiple Myeloma: A Prospective Study, Saad Jamshed, Rochester Regional Health, Mohammad Ammad-Ud-Din, Rochester Regional Health, Kimberly Celotto, et al.
5-6-2025 The Dying Process, Ricardo Beltran-Araujo, Rochester Regional Health
5-1-2025 Unveiling a 25-Year Journey: The Story of an Acquired Hemophilia Patient, Zeni Kharel, Rochester Regional Health; Mukul Singal, Indiana Hemophilia and Thrombosis Center, Indianapolis, Indiana.; and Ronald L. Sham, Rochester Regional Health
4-28-2025 Babesiosis unmasked in chronic lymphocytic leukemia: A case report, Himal Kharel, Rochester Regional Health; Zeni Kharel, Rochester Regional Health; and Pradyumna D. Phatak, Rochester Regional Health
4-8-2025 Thrombotic Microangiopathies (TMA), Ahmed Salman, Rochester Regional Health
4-1-2025 Plasmacytoma and Amyloidoma Presenting as an Iliac Mass, Zeni Kharel, Rochester Regional Health, Sungeun Kim, Rochester Regional Health, Roman M. Kowalchuk, Rochester Regional Health, et al.
3-20-2025 Unseen Hurdles in Cancer Care, Purva Shah, Rochester Regional Health and Robin M. Reid, Rochester Regional Health
2-27-2025 Elevated and Unexplained: Navigating Erythrocytosis and Thrombocytosis, Aniket-Vijay Rao, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
2-1-2025 Efficacy of PD-1 inhibitor plus chemotherapy versus chemotherapy in advanced esophageal carcinoma: A meta-analysis of phase III clinical trials, Zauraiz Anjum, Rochester Regional Health, Helai Hussaini, Shobha Mandal, et al.
2-1-2025 Efficacy of pembrolizumab in advanced esophageal carcinoma: A systematic review and meta-analysis, Helai Hussaini, Zauraiz Anjum, Rochester Regional Health, Shobha Mandal, et al.
1-16-2025 Thrombotic Microangiopathies, Ahmed Salman, Rochester Regional Health